Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.
about
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction.Sacubitril/Valsartan in an Elderly Patient with Heart Failure: A Case Report.Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients.
P2860
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@en
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@nl
type
label
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@en
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@nl
prefLabel
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@en
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@nl
P2093
P50
P1433
P1476
Angiotensin Receptor Neprilysi ...... esign of the PARAGON-HF Trial.
@en
P2093
Adel R Rizkala
Akshay S Desai
Carolyn S P Lam
Dirk J Van Veldhuisen
Felipe Martinez
Jean L Rouleau
Jianjian Gong
John J V McMurray
Marc A Pfeffer
P304
P356
10.1016/J.JCHF.2017.04.013
P577
2017-06-26T00:00:00Z